CPT code 38205 denotes the apheresis collection of hematopoietic progenitor cells (HPCs) from a donor’s peripheral blood using specialized apheresis equipment. This service is central to stem cell transplantation programs and cellular therapy supply chains, impacting hospital transplant services, donor centers, and outpatient apheresis units nationwide. Clear coding for HPC collection affects coverage determinations, claim adjudication, and operational workflows for transplant programs.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national perspective on clinical context and billing practice for HPC apheresis, including where the service is typically performed and why accurate CPT coding matters for transplant programs and payer interactions. The publication covers reimbursement benchmarks, common billing modifiers and service-line considerations, and relevant policy or coverage trends that influence payment and authorization processes.

This summary provides clinicians, coding professionals, and revenue managers with a clear, policy-focused overview of CPT code 38205, what it represents clinically, and the payer landscape relevant to collections of hematopoietic progenitor cells.